These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6574527)

  • 1. Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets.
    Beitz J; Panse M; Förster W
    Prostaglandins Leukot Med; 1983 Apr; 10(4):443-8. PubMed ID: 6574527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2 (TXA2) formation by washed human platelets under the influence of low and high density lipoproteins from healthy donors.
    Beitz J; Mest HJ
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):303-9. PubMed ID: 3094032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
    Best LC; Jones PB; Russell RG
    Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of lipoproteins (LDL and HDL) on PGI2-formation by isolated aortic preparations of rabbits.
    Giessler C; Beitz J; Mentz P; Förster W
    Prostaglandins Leukot Med; 1986 May; 22(2):221-34. PubMed ID: 3523542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HDL and LDL from pre and post menopausal women on prostacyclin synthesis.
    Beitz J; Müller G; Förster W
    Prostaglandins; 1985 Aug; 30(2):179-83. PubMed ID: 3901120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of thromboxane A2 synthase.
    Fitzpatrick FA; Jones D; Winitz S; Fish HT
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():161-3. PubMed ID: 1825535
    [No Abstract]   [Full Text] [Related]  

  • 7. Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase.
    McMillan RM; MacIntyre DE; Booth A; Gordon JL
    Biochem J; 1978 Nov; 176(2):595-8. PubMed ID: 743261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity.
    Beitz J; Förster W
    Biochim Biophys Acta; 1980 Dec; 620(3):352-5. PubMed ID: 6786342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxane synthase catalyses hydroxylations of prostaglandin H2 analogs in the presence of iodosylbenzene.
    Hecker M; Baader WJ; Weber P; Ullrich V
    Eur J Biochem; 1987 Dec; 169(3):563-9. PubMed ID: 3691505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
    Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
    Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased thromboxane B2 biosynthesis in platelets.
    Kawaguchi H; Ishibashi T; Imai Y
    Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
    Brammer JP; Kerecsen L; Maguire MH
    Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the thromboxane synthesizing system in human platelet microsomes.
    Tai HH; Yuan B
    Biochim Biophys Acta; 1978 Dec; 531(3):286-94. PubMed ID: 737191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.